Cambridge Investment Research Advisors
BXMX

Cambridge Investment Research Advisors’s Nuveen S&P 500 Buy-Write Income Fund BXMX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BXMX Stock Details BXMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-532,098
Closed -$7.82M – 3950
2025
Q4 		$7.82M Sell
532,098
-4,728
-0.9% -$67.9K 0.02% 693
2025
Q3 		$7.75M Sell
536,826
-30,505
-5% -$431K 0.02% 686
2025
Q2 		$7.88M Buy
567,331
+9,085
+2% +$119K 0.02% 645
2025
Q1 		$7.32M Buy
558,246
+12,051
+2% +$166K 0.02% 622
2024
Q4 		$7.64M Buy
546,195
+9,662
+2% +$134K 0.03% 600
2024
Q3 		$7.36M Buy
536,533
+20,720
+4% +$277K 0.03% 615
2024
Q2 		$6.96M Buy
515,813
+17,625
+4% +$230K 0.03% 602
2024
Q1 		$6.59M Buy
498,188
+6,070
+1% +$79.1K 0.03% 615
2023
Q4 		$6.31M Buy
492,118
+19,996
+4% +$250K 0.03% 594
2023
Q3 		$5.98M Buy
472,122
+41,722
+10% +$551K 0.03% 580
2023
Q2 		$5.75M Buy
430,400
+42,333
+11% +$559K 0.03% 596
2023
Q1 		$5.08M Buy
388,067
+18,886
+5% +$247K 0.02% 618
2022
Q4 		$4.67M Buy
369,181
+38,610
+12% +$498K 0.02% 632
2022
Q3 		$3.93M Buy
330,571
+24,694
+8% +$327K 0.02% 671
2022
Q2 		$3.78M Buy
305,877
+74,043
+32% +$997K 0.02% 721
2022
Q1 		$3.3M Buy
231,834
+11,649
+5% +$163K 0.02% 861
2021
Q4 		$3.23M Buy
220,185
+10,926
+5% +$161K 0.01% 879
2021
Q3 		$2.98M Buy
209,259
+8,072
+4% +$118K 0.01% 879
2021
Q2 		$2.89M Buy
201,187
+15,792
+9% +$222K 0.01% 918
2021
Q1 		$2.5M Sell
185,395
-11,069
-6% -$143K 0.01% 905
2020
Q4 		$2.53M Buy
196,464
+21,122
+12% +$253K 0.01% 804
2020
Q3 		$1.98M Buy
175,342
+19,072
+12% +$218K 0.01% 811
2020
Q2 		$1.72M Buy
156,270
+32,536
+26% +$354K 0.01% 841
2020
Q1 		$1.25M Sell
123,734
-2,179
-2% -$27.1K 0.01% 865
2019
Q4 		$1.73M Sell
125,913
-666
-0.5% -$9.01K 0.01% 851
2019
Q3 		$1.65M Sell
126,579
-410
-0.3% -$5.36K 0.01% 830
2019
Q2 		$1.69M Buy
126,989
+1,834
+1% +$24.1K 0.02% 785
2019
Q1 		$1.65M Sell
125,155
-155,355
-55% -$2.01M 0.02% 792
2018
Q4 		$3.39M Sell
280,510
-5,900
-2% -$77.6K 0.04% 451
2018
Q3 		$4.12M Buy
286,410
+37,829
+15% +$543K 0.04% 426
2018
Q2 		$3.5M Buy
248,581
+15,185
+7% +$212K 0.04% 446
2018
Q1 		$3.11M Buy
233,396
+34,211
+17% +$472K 0.04% 476
2017
Q4 		$2.84M Buy
199,185
+19,271
+11% +$270K 0.03% 469
2017
Q3 		$2.52M Buy
179,914
+11,501
+7% +$159K 0.03% 461
2017
Q2 		$2.33M Buy
168,413
+12,209
+8% +$169K 0.03% 460
2017
Q1 		$2.07M Sell
156,204
-9,562
-6% -$126K 0.04% 436
2016
Q4 		$2.11M Buy
165,766
+11,646
+8% +$148K 0.04% 418
2016
Q3 		$2.04M Buy
154,120
+36,757
+31% +$481K 0.04% 429
2016
Q2 		$1.53M Buy
117,363
+6,312
+6% +$80.8K 0.03% 443
2016
Q1 		$1.41M Buy
111,051
+9,784
+10% +$120K 0.03% 445
2015
Q4 		$1.36M Sell
101,267
-292
-0.3% -$3.74K 0.03% 457
2015
Q3 		$1.23M Buy
101,559
+23,434
+30% +$298K 0.04% 422
2015
Q2 		$1M Buy
78,125
+26,136
+50% +$335K 0.03% 506
2015
Q1 		$665K Buy
51,989
+6,782
+15% +$87.5K 0.02% 666
2014
Q4 		$547K Buy
45,207
+12,909
+40% +$164K 0.02% 735
2014
Q3 		$412K Buy
32,298
+11,059
+52% +$144K 0.01% 921
2014
Q2 		$278K Sell
21,239
-2,103
-9% -$27K 0.01% 1042
2014
Q1 		$295K Sell
23,342
-5,041
-18% -$62.9K 0.01% 966
2013
Q4 		$356K Sell
28,383
-533
-2% -$6.61K 0.01% 800
2013
Q3 		$349K Sell
28,916
-1,043
-3% -$13K 0.02% 772
2013
Q2 		$377K Buy
+29,959
New +$381K 0.02% 663

Other funds holding BXMX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.25B AUM 29.12% 1-Year Est. Return
CBT
CoreFirst Bank & Trust Topeka, Kansas $201M AUM 24.67% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
AWM
Ameliora Wealth Management Zurich, Switzerland $337M AUM 21.71% 1-Year Est. Return

Cambridge Investment Research Advisors's BXMX Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Nuveen S&P 500 Buy-Write Income Fund (BXMX) in Q1 2026, closing a stake of 532,098 shares — an estimated $7.82M sold.

Cambridge Investment Research Advisors first reported a position in BXMX in Q2 2013 and held it in 51 quarters. The position peaked at $7.88M in Q2 2025. 4 funds tracked by Wall St. Rank hold BXMX as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Nuveen S&P 500 Buy-Write Income Fund position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 532,098 Nuveen S&P 500 Buy-Write Income Fund shares in Q1 2026, an estimated $7.82M.
  • Cambridge Investment Research Advisors first reported a position in Nuveen S&P 500 Buy-Write Income Fund in Q2 2013 and held it in 51 quarters.
  • Cambridge Investment Research Advisors's Nuveen S&P 500 Buy-Write Income Fund position peaked at $7.88M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Nuveen S&P 500 Buy-Write Income Fund as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.